Scarica l'app Stockscreener
6.30
0.47%
-0.03
Pre-mercato:
6.33
0.03
+0.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$6.33
Aprire:
$6.37
Volume 24 ore:
3.42M
Relative Volume:
0.81
Capitalizzazione di mercato:
$1.55B
Reddito:
$407.32M
Utile/perdita netta:
$-61.60M
Rapporto P/E:
-24.46
EPS:
-0.2576
Flusso di cassa netto:
$-43.98M
1 W Prestazione:
+3.28%
1M Prestazione:
+9.00%
6M Prestazione:
+22.81%
1 anno Prestazione:
+35.78%
Intervallo 1D:
$6.21
$6.46
Intervallo di 1 settimana:
$5.95
$6.505
Portata 52W:
$3.21
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.30 | 1.55B | 407.32M | -61.60M | -43.98M | -0.2576 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx gains after insider purchase, LPGA marketing deal - MSN
Risk On: Can Ardelyx Inc stock outperform in a bear market2026 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
Chart Watch: Is The Bancorp Inc a top pick in the sector2026 Dividend Review & Daily Profit Maximizing Tips - baoquankhu1.vn
Activity Recap: Is Ardelyx Inc stock forming a triangle patternShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug PostEarnings: How does Ardelyx Inc correlate with Nasdaq2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
A Look At Ardelyx (ARDX) Valuation After The Appointment Of New Chief Medical Officer - Sahm
Dow Update: Is Ardelyx Inc stock forming a cup and handle2026 Action & Weekly Setup with ROI Potential - baoquankhu1.vn
Earnings Recap: Is Ardelyx Inc affected by consumer sentimentEarnings Miss & Smart Investment Allocation Insights - baoquankhu1.vn
Risk On: Will Ardelyx Inc stock benefit from M AQuarterly Trade Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Ardelyx, Inc. (ARDX) stock price, news, quote and history - Yahoo Finance UK
Could Ardelyx’s New CMO Reframe ARDX’s Long-Term Nephrology Pipeline Strategy? - Sahm
Is Ardelyx (ARDX) Offering Long-Term Value After Recent Share Price Swings? - Yahoo Finance
Ardelyx CMO Appointment Tests Growth Plans For Tenapanor Based Therapies - Yahoo Finance
Ardelyx names Rajani Dinavahi as CMO - The Pharma Letter
Ardelyx, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Ardelyx (ARDX) CMO details 301,000 options at $6.11 and 201,000 shares - Stock Titan
Ardelyx President and CEO Sells 41,000 Shares for $243,000 - Yahoo Finance
Ardelyx President and CEO Sells 41,000 Shares for $243,000 - The Motley Fool
ARDX PE Ratio & Valuation, Is ARDX Overvalued - intellectia.ai
Ardelyx names Rajani Dinavahi as chief medical officer By Investing.com - Investing.com South Africa
Assessing Ardelyx (ARDX) Valuation As New Chief Medical Officer Signals A Fresh Growth Phase - Sahm
Support Test: Is Ardelyx Inc stock forming a triangle pattern2026 Big Picture & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Ardelyx names Rajani Dinavahi as chief medical officer - Investing.com
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx - The Manila Times
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Trading Action: Can Ardelyx Inc stock double in the next yearMarket Risk Summary & Community Verified Watchlist Alerts - baoquankhu1.vn
Tech Rally: Is Ardelyx Inc affected by consumer sentiment2026 Institutional Moves & Technical Buy Zone Confirmation - baoquankhu1.vn
Ardelyx Investors Drop Appeal Over U-Turn on Medicare Program - Bloomberg Law News
Ardelyx, Inc. Stock Hits Day Low of $5.26 Amid Price Pressure - Markets Mojo
[SCHEDULE 13G/A] ARDELYX, INC. Amended Passive Investment Disclosure - Stock Titan
Ardelyx Stock Gaps Down Amid Weak Start and Market Concerns - Markets Mojo
Piper Sandler Maintains a Hold Rating on Ardelyx (ARDX) - MSN
Ardelyx's post-earnings decline attributed to concerns over Ibsrela outlook - MSN
ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan
ARDX stock is down pre-market after Q4 earnings miss, so why did this firm just hike price target by 80%? - MSN
Can Ardelyx Inc stock outperform in a bear market2026 Short Interest & Stepwise Trade Execution Plans - baoquankhu1.vn
ARDX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Insider Selling: Ardelyx (NASDAQ:ARDX) CEO Sells 41,666 Shares of Stock - MarketBeat
Raab, Ardelyx CEO, sells $243k in ARDX stock By Investing.com - Investing.com South Africa
Raab, Ardelyx CEO, sells $243k in ARDX stock - Investing.com
Ardelyx (ARDX) CEO exercises options, sells 41,666 shares under plan - Stock Titan
Ardelyx, Inc. Opens with 8.38% Gain, Contrasting Recent Performance Trends - Markets Mojo
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):